On January 20, 2023, Prabhdeep Singh notified Clover Health Investments, Corp. that he will be stepping down from his position as Chief Growth Officer of the Company, effective March 31, 2023. The Company intends to enter into a Separation and Consulting Agreement with Mr. Singh (the "Separation Agreement"), pursuant to which Mr. Singh will resign from his position as Chief Growth Officer of the Company, effective March 31, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.275 USD | +2.00% |
|
+9.57% | +32.34% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.34% | 621M | |
-7.28% | 444B | |
+14.75% | 124B | |
-22.12% | 42.84B | |
-8.23% | 36.25B | |
-14.40% | 18.02B | |
-29.64% | 2.46B | |
-13.82% | 1.39B |
- Stock Market
- Equities
- CLOV Stock
- News Clover Health Investments, Corp.
- Clover Health Investments, Corp. Announces Stepdown of Prabhdeep Singh as Chief Growth Officer, Effective March 31, 2023